<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00538928</url>
  </required_header>
  <id_info>
    <org_study_id>KKS 4012-001-07</org_study_id>
    <nct_id>NCT00538928</nct_id>
  </id_info>
  <brief_title>Extrapulmonary Interventional Ventilatory Support in Severe Acute Respiratory Distress Syndrome (ARDS)</brief_title>
  <acronym>Xtravent</acronym>
  <official_title>Extrapulmonary Interventional Ventilatory Support for Lung Protection in Severe Acute Respiratory Distress - a Prospective Randomized Multi Centre Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Regensburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Regensburg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, randomized study will be performed investigating the effects of a pumpless
      extracorporeal interventional lung assist [iLA] on the implementation of a lung-protective
      ventilatory strategy in patients with acute respiratory distress syndrome [ARDS] with a
      PaO2/FiO2 ratio &lt; 200. The duration of ventilation, intensive care and hospital stay and
      in-hospital mortality will be investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation group:

      Implantation of the iLA - adaptation of the ventilation strategy, explantation of the iLA
      after corresponding improvement (see treatment plan for details) - weaning from the
      ventilation and extubation according to specified criteria.

      Control group:

      Ventilation strategy based on the concept of lung-protective ventilation without
      extracorporeal support, weaning from the ventilation and extubation according to specified
      criteria (see treatment plan for details).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilator free days within 28 days after enrollment</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hospital mortality, organ-failure free days, pulmonary gas exchange</measure>
    <time_frame>28 days - 60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Implantation of the iLA - adaptation of the ventilation strategy, explantation of the iLA after corresponding improvement (see treatment plan for details) - weaning from the ventilation and extubation according to specified criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>no device: Ventilation strategy based on the concept of lung-protective ventilation without extracorporeal support, weaning from the ventilation and extubation according to specified criteria (see treatment plan for details).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>lung protective ventilation</intervention_name>
    <description>tidal volume 6 ml/kg ideal body weight</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The trial subjects are patients aged 18 years or older who have developed severe ARDS.
             Following the American-European Consensus Conference on ARDS, severe ARDS is defined
             as an oxygenation index (PaO2/FIO2) &lt; 200 mmHg. These parameters must be present for a
             duration of at least 2 hours.

        Exclusion Criteria:

          -  age &lt; 18 years

          -  decompensated heart insufficiency

          -  acute coronary syndrome

          -  severe chronic obstructive pulmonary disease

          -  advanced tumour conditions with life expectancy &lt; 6 months

          -  chronic dialysis treatment

          -  lung transplant patients

          -  proven Heparin-induced thrombocytopenia (HIT)

          -  morbid obesity (BMI &gt;) 40

          -  Child Class B and C cirrhosis of the liver, acute fulminant hepatic failure

          -  severe peripheral arterial occlusive disease (pAVK III - IV), absence of limb doppler
             pulse

          -  brain injury (GCS &lt; 9 + CT pathology)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Bein, Professor Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Regensburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steffen Weber-Carstens, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Charite University Hospital Berlin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Staudinger, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Vienna, Austria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sven Bercker, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Leipzig, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ralph Müllenbach, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Würzburg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rolf Dembinski, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Aachen, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93042</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Bein T, Weber F, Philipp A, Prasser C, Pfeifer M, Schmid FX, Butz B, Birnbaum D, Taeger K, Schlitt HJ. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med. 2006 May;34(5):1372-7.</citation>
    <PMID>16540950</PMID>
  </reference>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2007</study_first_submitted>
  <study_first_submitted_qc>October 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2007</study_first_posted>
  <last_update_submitted>March 1, 2011</last_update_submitted>
  <last_update_submitted_qc>March 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Department of Anesthesia</name_title>
    <organization>University Hospital</organization>
  </responsible_party>
  <keyword>acute respiratory distress syndrome</keyword>
  <keyword>extracorporeal lung support</keyword>
  <keyword>hypoxia</keyword>
  <keyword>hypercapnia</keyword>
  <keyword>acute respiratory distress syndrome (ARDS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

